Medical Device Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Class I, Class II, Class III), By Services (Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing, Device Manufacturing, Packaging & Labeling, Others), By Therapeutic Area (Cardiovascular Devices, Orthopedic Devices, Ophthalmic Devices, Diagnostic Devices, Respiratory Devices, Surgical Instruments, Dental, Others), By End Use (Original Equipment Manufacturers (OEMs), Pharmaceutical & Biopharmaceutical Companies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

What is the Size of Medical Device Contract Manufacturing Market?

The global medical device contract manufacturing market size was valued at USD 85.93 billion in 2025 and is projected to grow from USD 96.53 billion in 2026 to USD 244.68 billion by 2034, registering a CAGR of 12.33% during the forecast period from 2026 to 2034. North America dominated the medical device contract manufacturing market with a market share of 50.27% in 2025.

Product Insights

Class II devices dominated the medical device contract manufacturing market with a share of 83.45% in 2025 due to their broad use in diagnostic, monitoring, and therapeutic applications such as infusion pumps, imaging equipment, and surgical tools. These devices require controlled manufacturing processes and regulatory compliance, which encourages OEMs to outsource production to specialized contract manufacturers. The consistent demand for mid-complexity medical technologies supports segment growth.

The Class III devices segment is expected to grow at a CAGR of 13.23% during the forecast period, as demand increases for advanced implantable and life-supporting technologies such as cardiac implants and neurostimulation devices. These products require highly specialized manufacturing, precision engineering, and strict regulatory compliance. Many companies rely on experienced contract manufacturers with advanced capabilities to scale production, supporting rapid growth in this segment.

Request Customizationto receive a tailored report.

Services Insights

Accessories manufacturing dominated the services segment with a share of 51.24% in 2025, as a wide range of medical devices require compatible components such as connectors, tubing, sensors, and disposable accessories. Contract manufacturers play a key role in producing these high-volume components with consistent quality and cost efficiency. The recurring demand for accessories used with diagnostic and therapeutic devices sustains the segment’s leading market share.

The device manufacturing segment is expected to grow at a CAGR of 13.56% during the forecast period, as more medical device companies outsource full device production rather than only components. Contract manufacturers now provide integrated services including engineering, production, testing, and quality assurance. The need for scalable manufacturing capacity for complex medical technologies is accelerating the growth of outsourced device manufacturing services.

Therapeutic Area Insights

Cardiovascular devices dominated the therapeutic area segment with a share of 28.14% in 2025 due to the high global prevalence of heart diseases and the widespread use of devices such as stents, pacemakers, and monitoring systems. These products require precision manufacturing and strict regulatory compliance. Many manufacturers partner with contract manufacturers to ensure quality production and efficient scaling of cardiovascular device manufacturing.

The ophthalmic devices segment is expected to grow at a CAGR of 13.13%, driven by rising demand for vision correction technologies, diagnostic equipment, and minimally invasive eye surgery devices. The increasing number of cataract and retinal procedures has accelerated production needs. Contract manufacturers with micro-precision manufacturing capabilities support the rapid expansion of ophthalmic device production.

End Use Insights

Original equipment manufacturers dominated the end-use segment with a share of 54.23% in 2025, as many medical device companies outsource manufacturing to focus on research, product development, and commercialization. Contract manufacturers provide specialized production infrastructure, regulatory expertise, and scalable capacity. This allows OEMs to reduce operational costs while maintaining product quality and accelerating device market entry.

The pharmaceutical & biopharmaceutical companies segment is expected to grow at a CAGR of 13.23% during the forecast period due to the increasing development of drug-device combination products such as auto-injectors, inhalers, and wearable delivery systems. These products require integration of pharmaceutical formulation with device engineering. Contract manufacturers offer specialized production capabilities that support the expanding demand for combination therapy devices.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America Medical Device Contract Manufacturing Market

The North American market had a share of 50.27% in 2025. The market is growing due to strong innovation pipelines from universities, research hospitals, and federal research programs. The US National Institutes of Health (NIH) funds large volumes of biomedical engineering and medical technology research each year, creating a steady flow of prototype devices that require specialized external manufacturing for scaling and commercialization. The US also has a large network of small- and mid-size medical device innovators that often lack in-house manufacturing infrastructure and rely on contract manufacturers for precision machining, electronics integration, and sterile packaging. Many manufacturers outsource production to facilities that comply with US FDA Quality System Regulation (21 CFR Part 820) to ensure regulatory compliance and faster product approvals. The expansion of advanced technologies such as robotic surgery systems and connected diagnostic devices in US hospitals is increasing demand for contract manufacturers capable of producing high-precision electronic components and miniaturized device assemblies.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Medical Device Contract Manufacturing Market

The medical device contract manufacturing market in the Asia Pacific is expected to register a CAGR of 14.33% during the forecast period. The market is growing due to rapid growth of electronics and semiconductor manufacturing capabilities that support modern medical technologies. Countries such as Japan, South Korea, and Taiwan possess strong expertise in microelectronics, sensors, and precision component manufacturing, which are critical for wearable medical devices, imaging equipment, and diagnostic systems. Governments in the region are also developing specialized medical device industrial parks to support domestic production. For example, India has established dedicated medical device parks under government initiatives to improve infrastructure for device manufacturing and testing. The region’s strong supply chains for plastics, electronics, and metal fabrication allow contract manufacturers to produce complex device components efficiently. The rising adoption of digital health technologies and portable monitoring devices across Asia Pacific healthcare systems is also increasing demand for electronics-focused contract manufacturing services.

Europe Medical Device Contract Manufacturing Market

The market in Europe is strongly influenced by strong innovation pipelines from universities, research hospitals, and federal research programs. The US National Institutes of Health (NIH) funds large volumes of biomedical engineering and medical technology research each year, creating a steady flow of prototype devices that require specialized external manufacturing for scaling and commercialization. The US also has a large network of small- and mid-size medical device innovators that often lack in-house manufacturing infrastructure and rely on contract manufacturers for precision machining, electronics integration, and sterile packaging. Many manufacturers outsource production to facilities that comply with US FDA Quality System Regulation (21 CFR Part 820) to ensure regulatory compliance and faster product approvals. The expansion of advanced technologies such as robotic surgery systems and connected diagnostic devices in US hospitals is increasing demand for contract manufacturers capable of producing high-precision electronic components and miniaturized device assemblies.

Middle East & Africa Medical Device Contract Manufacturing Market

The medical device contract manufacturing market in the Middle East & Africa is developing as governments increase investments in healthcare infrastructure and aim to strengthen regional medical technology capabilities. Many countries in the region are implementing national healthcare modernization programs that increase demand for diagnostic equipment, monitoring devices, and hospital technologies. Governments are also encouraging local production of medical equipment to reduce dependence on imports and strengthen supply chain resilience. The expansion of hospital networks, medical cities, and specialized healthcare facilities across countries such as Saudi Arabia and the United Arab Emirates creates opportunities for partnerships with international contract manufacturers. The growing adoption of advanced healthcare technologies and the gradual development of regulatory frameworks are supporting the emergence of regional medical device manufacturing activities.

Latin America Medical Device Contract Manufacturing Market

Latin America is witnessing gradual growth in medical device contract manufacturing driven by expanding healthcare demand and increasing manufacturing activities in countries such as Brazil and Mexico. Mexico has developed into an important medical device manufacturing hub due to its proximity to the US market and strong export-oriented manufacturing ecosystem. The presence of industrial clusters and trade agreements with North American markets encourages international device manufacturers to establish production partnerships with contract manufacturers in the region. Brazil also represents a major healthcare market in Latin America, with increasing government investments in healthcare services and medical technology procurement. The expansion of regional healthcare systems and growing demand for cost-effective medical technologies are encouraging outsourcing of device production to local manufacturing partners across the region.

Competitive Landscape

The medical device contract manufacturing market is highly fragmented, comprising a mix of established multinational corporations, regional players, and innovative niche companies. Established players primarily compete on factors such as brand reputation, large-scale manufacturing capabilities, distribution networks, and regulatory compliance, leveraging their experience and resources to maintain market share. Emerging players, on the other hand, focus on innovation, specialized product offerings, cost-effectiveness, and agility to quickly address evolving customer needs. In the future, the market will be shaped by technological advancements, regulatory shifts, and the ability of players to deliver differentiated, sustainable, and patient-centric solutions.

List of Key and Emerging Players in Medical Device Contract Manufacturing Market